Location History:
- Cardiff by the Sea, CA (US) (2013)
- San Diego, CA (US) (2016 - 2019)
Company Filing History:
Years Active: 2013-2019
Title: Innovations of Gregg Alan Timony
Introduction
Gregg Alan Timony is an accomplished inventor based in San Diego, California. He has made significant contributions to the field of pharmaceutical sciences, particularly in the modulation of sphingosine 1 phosphate receptors. With a total of three patents to his name, Timony's work has implications for the treatment of various diseases and disorders.
Latest Patents
Timony's latest patents focus on selective sphingosine 1 phosphate receptor modulators and methods of chiral synthesis. These patents describe compounds that selectively modulate the sphingosine 1 phosphate receptor, specifically targeting subtype 1 of the S1P receptor. The patents also detail methods of chiral synthesis for these compounds. Furthermore, they outline uses, treatment methods, and preventive measures associated with the modulation of the sphingosine 1 phosphate receptor, which is medically indicated for various conditions.
Career Highlights
Throughout his career, Gregg Alan Timony has worked with notable companies in the pharmaceutical industry. He has been associated with Receptos, Inc. and Celgene International II Sàrl, where he contributed to innovative research and development projects. His expertise in receptor modulation has positioned him as a key figure in advancing therapeutic options.
Collaborations
Timony has collaborated with several professionals in his field, including Esther Martinborough and Marcus F. Boehm. These collaborations have fostered
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.